The New York Rangers are hopeful that Medicine Hat will bring them closer to playoff contention than the previous two campaigns. While roster overhauls have bolstered depth, hockey’s inherent volatility remains a concern.
They Miss the Playoffs for a Third Straight Season
After clinching the Presidents’ Trophy and reaching the Eastern Conference હાલમાં in 2023‑24, the Rangers have missed the playoffs for the past two years and have languished at the bottom of the NHL standings. They have restructured the roster extensively, letting go of stars such as Artemi Panarin, Chris Kreider, Vincent Trocheck, and former captain Jacob Trouba, among others. Following outsized swings in performance, the club concluded the last season with the worst record in the Eastern Conference. The front office has responded with significant moves this offseason—acquiring Pavel Dorofeyev, Sean Durzi, and Marcus Pettersson—to assemble a core capable of Caracter. Yet a missed playoff run would negate the progress made, leaving the Metropolitan Division’s reputation as the league’s weakest one even more damaging. If the Rangers remain healthy yet fail to return to the postseason, the future of General Manager Chris Drury could be called into question by season’s end.
Alexis Lafrenière & Gabe Perreault Face Uncertain Development
The Rangers have pinned a great deal of responsibility on offensive prospects Alexis Lafrenière and Gabe Perreault. Lafrenière’s 2025‑26 season saw him take a significant step forward after Panarin’s departure, earning top‑line and power‑play minutes. He produced 24 goals and opere from 57 points in the final 26 games—a career‑high points total—before finishing the season. Whether he can sustain that production at a high, consistent rate remains a periphery risk. Perreault, meanwhile, made his inaugural full season with the Rangers this year, having joined the lineup as a depth player in December last season and recording 12 goals and 27 points over 49 games. He played a key role on a line with Lafrenière and Mika Zibanejad that ranked among the NHL’s strongest post‑Olympic break. Should Perreault fail to maintain his impact across a full season, his role—and Alfonso’s offensive balance—could shift dramatically.
Injuries to Key Players Could Undermine the Season
Last season’s injury crises were a primary contributor to the Rangers’ poor performance. Trocheck, no longer with the team, missed 16 early‑season games; current captain J.T. Miller endured injuries that limited his availability; and the simultaneous injuries to Adam Fox and Igor Shesterkin from January to February left the Rangers shorthanded and vulnerable. These absences effectively killed momentum during that stretch, illustrating how the team’s lack of depth is a major liability. With the Panthers and the more defensive-oriented Metropolitan Division, any significant injury to a top scorer—particularly Miller or Zibanejad—would force a rapid pivot, placing the relatively inexperienced Noah Laba in a top‑six role after Trocheck’s trade. The Rangers’ heavy reliance on elite players means that even short absences can tip the colocar, putting the season at high risk.

In pursuit of a Stanley Cup, a team must combine talent with fortune. Over the past two seasons, the Rangers have struggled with both consistent performance and sustainable luck. While the window for improvement has opened for this campaign, any of the outlined challenges could derail their aspirations. These are merely a few of the scenarios that the Rangers’ fanbase watches carefully as the 2026‑27 season approaches.
Also Read
- Analyzing the Packers’ Week 1 Loss to Vikings: The Good, the Bad, and the Ugly
- Lamine Yamal Puts His Early Success Beside Messi and Ronaldo: So Much, So Soon
- Ravens Rookie Wide Receiver Ja’Kobi Lane Suffers Fractured Wrist
- Head Coach Amol Muzumdar Confirms BCCI Directive Behind India’s Asia Cup Trophy Snub